EXECUTIVE CHANGES: Phoenix Copper suspends chair and CFO
(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News: Read More
| Price | 126.00p on 17-02-2026 at 18:35:11 |
|---|---|
| Change | -2.00p -1.56% |
| Buy | 129.50p |
| Sell | 125.00p |
| Last Trade: | Buy 6,320.00 at 126.00p |
| Day's Volume: | 62,934 |
| Last Close: | 126.00p |
| Open: | 133.50p |
| ISIN: | GB00BVV2KN49 |
| Day's Range | 126.00p - 133.50p |
| 52wk Range: | 115.00p - 171.00p |
| Market Capitalisation: | £124.26m |
| VWAP: | 127.21158p |
| Shares in Issue: | 98.62m |
Eurocell (ECEL) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 6,320 | 126.00p | Suspected BUY Trade |
16:35:28 - 17-Feb-26 |
| Sell* | 29 | 127.00p | Automatic Execution |
16:29:55 - 17-Feb-26 |
| Sell* | 220 | 126.50p | SI Trade |
15:34:25 - 17-Feb-26 |
| Sell* | 13,000 | 127.4964p | Ordinary |
15:13:58 - 17-Feb-26 |
| Sell* | 1 | 126.50p | SI Trade |
14:00:01 - 17-Feb-26 |
| Buy* | 5 | 130.00p | SI Trade |
13:42:35 - 17-Feb-26 |
| Buy* | 7,010 | 128.00p | Automatic Execution |
13:37:38 - 17-Feb-26 |
| Buy* | 7,010 | 127.75p | Ordinary |
13:37:30 - 17-Feb-26 |
| Sell* | 15,900 | 126.42p | Ordinary |
13:09:53 - 17-Feb-26 |
| Buy* | 9,369 | 127.378p | Ordinary |
13:07:44 - 17-Feb-26 |
Eurocell (ECEL) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 16th Feb 2026 7:00 am | RNS | Transaction in Own Shares |
| 13th Feb 2026 7:00 am | RNS | Transaction in Own Shares |
| 12th Feb 2026 7:00 am | RNS | Transaction in Own Shares |
| 11th Feb 2026 7:00 am | RNS | Transaction in Own Shares |
| 10th Feb 2026 7:00 am | RNS | Transaction in Own Shares |
| 9th Feb 2026 1:00 pm | RNS | Directorate changes |
| 9th Feb 2026 7:00 am | RNS | Transaction in Own Shares |
| 6th Feb 2026 7:00 am | RNS | Transaction in Own Shares |
| 4th Feb 2026 7:00 am | RNS | Transaction in Own Shares |
| 3rd Feb 2026 7:00 am | RNS | Director/PDMR Shareholding |